期刊
NEUROREPORT
卷 12, 期 10, 页码 2097-2100出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00001756-200107200-00011
关键词
asimadoline; neurogenic inflammation; neuropeptides; norepinephrine; pain
Norepinephrine (NE) reduces the release of neuropeptides from central terminals of primary afferent neurones by presynaptic inhibition. We investigated whether NE also affects stimulus-induced intracutaneous calcitonin gene-related peptide (CGRP) and secondary prostaglandin E-2 (PGE(2)) release. For comparison. kappa -opioid effects were examined. Antidromic electrical nerve stimulation resulted in significant increases in the release of CGRP and PGE(2). The PGE(2) release was prevented by selective activation of alpha (2)-adrenoceptors whereas the CGRP release was not changed. In contrast, selective kappa -opioid receptor activation diminished electrically evoked release of both CGRP and PGE-(2). We conclude that NE affected stimulated PGE(2) release via alpha (2)-adrenoceptors on cells other than cutaneous afferents while kappa -opioid receptors are expressed in peripheral terminals of cutaneous afferents and their activation reduced CGRP release and secondary PGE(2) formation. NeuroReport 12:2097-2100 (C) 2001 Lippincott Williams & Wilkins.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据